Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [ID6720]

  • Awaiting development
  • GID-TA11874
  • Expected publication date: TBC

34081-Pozelimab-Cemdisiran-for-Myasthenia-Gravis-V1.0-SEP2025-NON-CONF.pdf34081-Pozelimab-Cemdisiran-for-Myasthenia-Gravis-V1.0-SEP2025-NON-CONF.pdf